HIV感染者肠杆菌耐药率高于非HIV感染者
研究分析美国北卡罗来纳州2000-2018年36 521例肠杆菌培养阳性患者,其中440例为HIV感染者。HIV感染者多重耐药肠杆菌总患病率为21.5%,非HIV感染者为16.5%,调整患病率比为1.38(95%CI 1.14-1.65)。所有分析抗生素类别的耐药率在HIV感染者中均更高。
要点
- HIV感染者多重耐药肠杆菌患病率21.5%,高于非HIV感染者的16.5%。
- 调整患病率比1.38(95%CI 1.14-1.65),提示HIV感染与耐药独立相关。
- 所有分析抗生素类别耐药率在HIV感染者中均更高,需关注抗菌药物管理。
核心结论
- 2000-2018年美国东南部大型临床人群中,HIV感染者肠杆菌耐药率持续高于非HIV感染者。
研究设计与样本
- 回顾性分析北卡罗来纳州医疗系统36 521例肠杆菌培养阳性患者,其中440例为HIV感染者,采用广义线性模型估计患病率比和差值,并用5年移动平均及限制性立方样条评估趋势。
主要发现
- HIV感染者多重耐药肠杆菌总患病率为21.5%(95%CI 18.2%-25.1%),非HIV感染者为16.5%(95%CI 16.2%-16.9%)。
- 调整患病率比为1.38(95%CI 1.14-1.65)。
- HIV感染者对所有分析抗生素类别(包括青霉素类、青霉素/β-内酰胺酶抑制剂复方、磺胺类)的耐药率均高于非HIV感染者。
- 基于5年移动平均,整个研究期间HIV感染者多重耐药肠杆菌患病率比非HIV感染者高3至10个百分点。
临床怎么用
- 临床应识别并干预HIV感染者中促进抗菌药物耐药的因素,以应对耐药病原体潜在临床后果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multidrug-resistant Enterobacterales (MDR-E) are important pathogens. People living with human immunodeficiency virus (HIV; PLWH) may be at greater risk for MDR-E infection given relatively high antibiotic exposure and burden of comorbidities. METHODS: We analyzed data from 36 521 patients in a healthcare system in North Carolina who had a clinical culture with growth of an Enterobacterales species from 2000 to 2018; 440 were PLWH. We used generalized linear models to estimate prevalence ratios and differences, contrasting PLWH and people not living with HIV (PNLWH) for resistance to individual antibiotic classes, as well as MDR-E. We assessed trends in prevalence over time by calculating the 5-year moving average and fitting restricted cubic spline models. RESULTS: The overall prevalence of MDR-E was higher among PLWH (21.5%; 95% confidence interval [CI], 18.2%-25.1%) vs PNLWH (16.5%; 95% CI, 16.2%-16.9%), with an adjusted prevalence ratio of 1.38 (95% CI, 1.14-1.65). PLWH had higher rates of antimicrobial resistance than PNLWH for all antibiotic classes analyzed, including penicillins, penicillin/beta lactamase inhibitor combinations, and sulfonamides. MDR-E prevalence was 3 to 10 percentage points higher among PLWH than PNLWH throughout the study period based on the 5-year moving average. CONCLUSIONS: In a large clinical study population in the southeastern United States from 2000 to 2018, the prevalence of antibacterial resistance among Enterobacterales was consistently higher among PLWH than PNLWH. These data highlight the importance of identifying and mitigating the factors that contribute to antimicrobial resistance in PLWH, given the potential clinical consequences of these resistant pathogens.
引用
- Henderson HI, Napravnik S, Gower EW, et al. Resistance in Enterobacterales Is Higher Among People Living With Human Immunodeficiency Virus. Clin Infect Dis. 2022. PMID: 34643220. doi:10.1093/cid/ciab901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。